Related Experiment Video
Updated: Mar 10, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
miR-206 inhibits renal cell cancer growth by targeting GAK
Chao Wei1,2, Shen Wang1,2, Zhang-Qun Ye1,2
1Department of Urology, Huazhong University of Science and Technology, Wuhan, 430030, China.
Abstract:
Renal cell cancer (RCC) remains one of the most lethal types of cancer in adults. MicroRNAs (miRNAs) play key roles in the pathogenesis of RCC. The role of miR-206 in RCC has not been fully understood. The purpose of this study was to examine the role of miR-206 in the regulation of proliferation and metastasis of RCC and the possible mechanism. miR-206 expression was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in RCC cell lines (786-O and OS-RC-2 cells) and clinical samples. MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] method, colony formation and transwell assay were used to detect the tumor-suppressing ability of miR-206 in RCC. Luciferase assay was performed to verify the precise target of miR-206. The results showed that the expression of miR-206 was significantly down-regulated in RCC tissues and cells. The expression level of cyclin G-associated kinase (GAK), a master regulator of tumor proliferation and metastasis, was up-regulated with the decrease in miR-206 in RCC tissues as well as RCC cell lines. In addition, the miR-206 inhibitor promoted the proliferation, migration and invasion of 786-O and OS-RC-2 cells. Bioinformatics combined with luciferase and Western blot assays revealed that miR-206 inhibited the expression of GAK. Moreover, miR-206 regulates RCC cell growth partly through targeting GAK. Our study indicated that miR-206 functions as a tumor suppressor in regulating the proliferation, migration and invasion of RCC by directly targeting GAK, and it holds promises as a potential therapeutic target for RCC.
Insights
MicroRNA-206 (miR-206) acts as a tumor suppressor in renal cell cancer (RCC). Its reduced expression promotes RCC proliferation and metastasis by upregulating cyclin G-associated kinase (GAK).
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal cell cancer (RCC) is a highly lethal malignancy.
- MicroRNAs (miRNAs) are implicated in RCC pathogenesis.
- The specific role of miR-206 in RCC requires further elucidation.
Purpose of the Study:
- To investigate the role of miR-206 in regulating RCC proliferation and metastasis.
- To identify the underlying molecular mechanism of miR-206 action in RCC.
Main Methods:
- Quantitative reverse transcription PCR (RT-qPCR) for miR-206 expression analysis.
- Cell proliferation assays (MTS, colony formation) and migration/invasion assays (Transwell).
- Bioinformatics, luciferase assays, and Western blot to identify and validate miR-206 targets.
Main Results:
- miR-206 expression was significantly downregulated in RCC tissues and cell lines.
- miR-206 inhibition promoted RCC cell proliferation, migration, and invasion.
- Cyclin G-associated kinase (GAK) expression was inversely correlated with miR-206 levels and identified as a direct target of miR-206.
Conclusions:
- miR-206 functions as a tumor suppressor in RCC by inhibiting proliferation and metastasis.
- miR-206 exerts its effects through direct targeting of GAK.
- miR-206 represents a potential therapeutic target for renal cell cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle
Abnormal Proliferation

